Milrod Barbara, Leon Andrew C, Busch Fredric, Rudden Marie, Schwalberg Michael, Clarkin John, Aronson Andrew, Singer Meriamne, Turchin Wendy, Klass E Toby, Graf Elizabeth, Teres Jed J, Shear M Katherine
Weill Medical College of Cornell University, 525 East 68th St., New York, NY 10021, USA.
Am J Psychiatry. 2007 Feb;164(2):265-72. doi: 10.1176/ajp.2007.164.2.265.
The purpose of this study was to determine the efficacy of panic-focused psychodynamic psychotherapy relative to applied relaxation training, a credible psychotherapy comparison condition. Despite the widespread clinical use of psychodynamic psychotherapies, randomized controlled clinical trials evaluating such psychotherapies for axis I disorders have lagged. To the authors' knowledge, this is the first efficacy randomized controlled clinical trial of panic-focused psychodynamic psychotherapy, a manualized psychoanalytical psychotherapy for patients with DSM-IV panic disorder.
This was a randomized controlled clinical trial of subjects with primary DSM-IV panic disorder. Participants were recruited over 5 years in the New York City metropolitan area. Subjects were 49 adults ages 18-55 with primary DSM-IV panic disorder. All subjects received assigned treatment, panic-focused psychodynamic psychotherapy or applied relaxation training in twice-weekly sessions for 12 weeks. The Panic Disorder Severity Scale, rated by blinded independent evaluators, was the primary outcome measure.
Subjects in panic-focused psychodynamic psychotherapy had significantly greater reduction in severity of panic symptoms. Furthermore, those receiving panic-focused psychodynamic psychotherapy were significantly more likely to respond at treatment termination (73% versus 39%), using the Multicenter Panic Disorder Study response criteria. The secondary outcome, change in psychosocial functioning, mirrored these results.
Despite the small cohort size of this trial, it has demonstrated preliminary efficacy of panic-focused psychodynamic psychotherapy for panic disorder.
本研究旨在确定针对惊恐障碍的心理动力心理治疗相对于应用放松训练(一种可靠的心理治疗对照条件)的疗效。尽管心理动力心理治疗在临床中广泛应用,但评估此类心理治疗对轴I障碍疗效的随机对照临床试验却滞后了。据作者所知,这是第一项针对惊恐障碍的心理动力心理治疗(一种针对DSM-IV惊恐障碍患者的手册化精神分析心理治疗)的疗效随机对照临床试验。
这是一项针对原发性DSM-IV惊恐障碍患者的随机对照临床试验。在5年时间里于纽约市大都市区招募参与者。受试者为49名年龄在18至55岁之间的患有原发性DSM-IV惊恐障碍的成年人。所有受试者接受指定治疗,即针对惊恐障碍的心理动力心理治疗或应用放松训练,每周两次,为期12周。由盲法独立评估者评定的惊恐障碍严重程度量表是主要结局指标。
接受针对惊恐障碍的心理动力心理治疗的受试者惊恐症状严重程度的降低幅度显著更大。此外,根据多中心惊恐障碍研究反应标准,接受针对惊恐障碍的心理动力心理治疗的受试者在治疗结束时更有可能产生反应(73%对39%)。次要结局,即心理社会功能的变化,也反映了这些结果。
尽管本试验的队列规模较小,但已证明针对惊恐障碍的心理动力心理治疗具有初步疗效。